Retatrutide 1.5mg

Retatrutide 1.5mg: Current Insights & Expected Effects
Retatrutide (Eli Lilly’s GIP/GLP-1/Glucagon triple agonist) is still in clinical trials, and while 1.5mg has not been a primary focus in published studies, we can extrapolate its likely role based on available data.

1. Likely Purpose of the 1.5mg Dose

Possible titration dose (between 1mg and 2mg) to help patients adjust gradually and minimize side effects.

Similar to how tirzepatide (Mounjaro/Zepbound) uses 2.5mg → 5mg → 7.5mg, Retatrutide may follow a stepwise approach (e.g., 1mg → 1.5mg → 2mg → 4mg, etc.).

Not expected to be a maintenance dose—higher doses (≥4mg) show the most weight loss benefits.

2. Expected Efficacy (Based on Phase 2 Data)

Weight Loss:

1.5mg alone likely results in <10% weight loss (similar to 1mg and 2mg).

Higher doses (4mg-12mg) achieved ~17-24% weight loss at 48 weeks—far more impactful.

Blood Sugar Control:

Mild HbA1c reduction (similar to low-dose GLP-1s), but not as strong as 4mg+ doses.

3. Side Effects at 1.5mg

Should be milder than higher doses but may still include:

Most common: Nausea, mild diarrhea, constipation.

Less likely: Severe GI distress, pancreatitis (very rare at this dose).

Glucagon activity at this dose is minimal, so unlikely to significantly increase heart rate.

4. How Does 1.5mg Compare to Other Doses?

Dose
Expected Weight Loss
Likely Role

1mg
~5-8%
Starting dose

1.5mg
~6-9%
Intermediate titration

2mg
~7-10%
Mid-level titration

4mg+
15-24%
Therapeutic range

5. When Could Retatrutide 1.5mg Be Available?

Still in Phase 3 trials (expected completion 2025-2026).

Possible FDA approval: 2026-2027 (if results are strong).

Commercial form: Likely in a multi-dose pen (similar to Mounjaro/Zepbound) allowing flexible dosing.

Key Takeaways
🔹 1.5mg is likely a stepping-stone dose—not for maximal efficacy but to ease patients into treatment.
🔹 Higher doses (4mg-12mg) show dramatic weight loss (~17-24%)—1.5mg is just the beginning.
🔹 Side effects should be mild, making it tolerable for most.
🔹 Not yet FDA-approved—awaiting Phase 3 results for confirmation.
Would you like details on:

How this compares to Retatrutide 4mg or 8mg?

Latest trial updates (2024)?

Possible dosing schedules (similar to Mounjaro)?